P557: HEMATOLOGIC IMPROVEMENTS WITH IVOSIDENIB + AZACITIDINE COMPARED WITH PLACEBO + AZACITIDINE IN PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA

• H. Dohner,
• P. Montesinos,
• S. Vives Polo,
• E. Zarzycka,
• J. Wang,
• G. Bertani,
• M. Heuser,
• R. Calado,
• A. Schuh,
• S.-P. Yeh,
• A. de la Fuente,
• C. Cerchione,
• S. Daigle,
• J. Hui,
• S. Pandya,
• D. Gianolio,
• C. Recher,
• S. de Botton

Affiliations

H. Dohner

1 Ulm University Hospital, Ulm, Germany

P. Montesinos

2 Hospital Universitari i Politècnic La Fe, València

S. Vives Polo

3 Hospital Universitario Germans Trias i Pujol-ICO Badalona, Josep Carreras Research Institute, Badalona, Spain

E. Zarzycka

4 Department of Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland

J. Wang

5 Institute of Hematology & Hospital of Blood Disease, Tianjin, China

G. Bertani

6 ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy

M. Heuser

7 Hannover Medical School, Hannover, Germany

R. Calado

8 Ribeirão Preto School of Medicine, University of São Paulo, São Paulo, Brazil

A. Schuh

9 Princess Margaret Cancer Centre, Toronto, Canada

S.-P. Yeh

10 China Medical University, Taichung, Taiwan

A. de la Fuente

11 MD Anderson Cancer Center Madrid, Madrid, Spain

C. Cerchione

12 Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

S. Daigle

13 Servier Pharmaceuticals, Boston, United States of America

J. Hui

13 Servier Pharmaceuticals, Boston, United States of America

S. Pandya

13 Servier Pharmaceuticals, Boston, United States of America

D. Gianolio

13 Servier Pharmaceuticals, Boston, United States of America

C. Recher

14 Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse

S. de Botton

15 Institut Gustave Roussy, Villejuif, France